# ZIOPTAN

NDC: 82584-609
Generic name: Tafluprost
Labeler / Manufacturer: Thea Pharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20221028

FDA application: NDA202514

## Active ingredients

- TAFLUPROST: .015 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82584-609"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82584-609
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db529b54-2ac7-4020-9791-7333bbe6c90f